Propofol requirement titrated to bispectral index: a comparison between hypothermic and normothermic cardiopulmonary bypass

Abstract

Though propofol requirement is expected to decrease during cardiopulmonary bypass (CPB), a few studies have failed to demonstrate this. The factors affecting pharmacokinetics of propofol and, therefore, the requirement, are different during hypothermic and normothermic CPB. We evaluated and compared the requirement of propofol during hypothermic and normothermic CPB. Fifty adult patients scheduled for elective cardiac surgery on CPB were recruited and randomly allocated into hypothermic CPB (28–30⁰ C) (Group H) and normothermic CPB (35–37⁰ C) (Group N) groups. Patients were induced and maintained with propofol titrated to maintain a target bispectral index (BIS) of 50 ± 10. Propofol requirement (mean ± SD) was similar in normothermic and hypothermic groups, both before CPB (4.9 ± 1.5 mg.kg⁻¹hr⁻¹ in Group N, 4.6 ± 1.5 mg.kg⁻¹hr⁻¹ in Group H) and after cessation of bypass (p > 0.05) (4.6 ± 1.8 mg.kg⁻¹hr⁻¹ in Group N and 4.3 ± 1.7 mg.kg⁻¹hr⁻¹ in Group H). CPB significantly reduced (p < 0.001) propofol requirements in both arms of the study (Group N: 2.9 ± 1.4 mg.kg⁻¹hr⁻¹and Group H: 1.3 ± 0.7 mg.kg⁻¹hr⁻¹). This reduction was more pronounced in the hypothermic group (p < 0.001). The BIS (median ± inter quartile range) remained constant during normothermic CPB (50 ± 8.8), but declined significantly during hypothermic CPB (41 ± 5.6) despite decreased usage of propofol during hypothermia. No patient had recall of intra-operative events. CPB decreases the magnitude of propofol requirements and the effect of hypothermic CPB is significantly more than that of normothermic CPB.

Keywords

bispectral index cardiopulmonary bypass hypothermia normothermia propofol requirement

Get full access to this article

View all access options for this article.

References

1 Lee H Khoo Y Chua B Ng A Tan S Chew S . Pharmacokinetics of propofol infusion in Asian patients undergoing coronary artery bypass grafting. Ther Drug Monit 1995; 17: 336–341.

2 Russell GN Wright EL Fox MA . Propofol-fentanyl anaesthesia for coronary artery surgery and cardiopulmonary bypass. Anaesthesia 1989; 44: 205–208.

3 Hammaren E Yli-Hankala A Rosenberg PH Hynynen M . Cardiopulmonary bypass induced changes in plasma concentrations of propofol and in auditory evoked potentials. Br J Anesth 1996; 77: 360–364.

4 Hynynen M Hammeren E Rosenberg PH . Propofol sequestration within extracorporeal circuit. Can J Anaesth 1994; 41: 583–588.

5 McAllister RG Tan TG . Effect of hypothermia on drug metabolism. In vitro studies with propanolol and verapamil. Pharmacology 1980; 20: 95–100.

6 Yoshitani K Kawaguchi M Takahashi M Kitaguchi K Furuya H . Plasma propofol concentration and EEG burst suppression ratio during normothermic cardiopulmonary bypass. Br J Anesth 2003; 90: 122–126.

7 Schmidlin D Hager P Schimd ER . Monitoring level of sedation with Bispectral EEG analysis: comparison between hypothermic and normothermic cardiopulmonary bypass. Br J Anesth 2001; 86: 769–776.

8 Vanhemelrijk J Tempelhoff R White PF . EEG assisted titration of propofol infusion during neuroanaesthesia: effect of nitrous oxide. J Neurosurg Anesth 1992; 4: 11–20.

9 Ahonen J Sahlman A Yli-Hankala A . No effect of cardiopulmonary bypass on hypnosis in patients anaesthetized with propofol and alfentanil. Br J Anesth 2004; 92: 137–139.

10.

10 Liu J Singh H White PF . Electroencephalographic bispectral index correlates with intraoperative recall and depth of propofol induced sedation. Anesth Analg 1997; 84: 185–189.

11.

11 Puri GD Murthy SS . Bispectral index monitoring in patients undergoing cardiac surgery under cardiopulmonary bypass. Eur J Anaesthesiol 2003; 20: 451–456.

12.

12 Nordstrom O Engstrom AM Persson S . Incidence of awareness in total i.v. anaesthesia based on propofol, alfentanil and neuromuscular blockade. Acta Anaesthesiol Scand 1997; 41: 978–984.

13.

13 Kuipers JA Boer F Olieman W . First-pass lung uptake and pulmonary clearance of propofol: assessment with a recirculatory indocyanine green pharmacokinetic model. Anaesthesiology 1999; 91: 1780–1787.

14.

14 Wilkinson G . Pharmacokinetics of drug disposition: hemodynamic considerations. Ann Rev Pharmacol 1975; 15: 11–27.

15.

15 Harris DNF Bailey SM Smith PLC . Brain swelling in the first hour after coronary artery bypass surgery. Lancet 1993; 342: 586–587.

16.

16 Anderson RE Li T-Q Hindmarsh T Settergren G Vaage J . Increased extracellular brain water coronary artery bypass grafting is avoided by off-pump surgery. J Cardiothorac Vasc Anesth 1999; 13: 698–702.